City
Epaper

WHO experts back Covid booster dose for immunocompromised

By IANS | Updated: October 12, 2021 09:05 IST

Geneva, Oct 12 Experts from the World Health Organization (WHO) have recommended that Covid-19 booster shots should be ...

Open in App

Geneva, Oct 12 Experts from the World Health Organization (WHO) have recommended that Covid-19 booster shots should be offered to moderately and severely immunocompromised people.

After four days of talks last week, the WHO's Strategic Advisory Group of Experts on Immunization (SAGE) on Monday recommended that such people should receive a third dose of a vaccine on the WHO Emergency Use Listing (UEL) as they are "less likely to respond adequately to vaccination following a standard primary vaccine series and are at high risk of severe Covid-19 disease", reports Xinhua news agency.

Since the end of September, several Covid-19 vaccines have been certified by the WHO UEL, including Pfizer-BioNTech, Janssen, Moderna, Sinopharm, Sinovac, AstraZeneca, and Covishield.

SAGE said it had also reviewed COVAXIN, made by India's Bharat Biotech, and a policy recommendation will be issued once the vaccine is approved by the WHO UEL.

Third doses of the Chinese Sinovac and Sinopharm inactivated virus vaccines should be offered to those over 60, said WHO experts.

Meanwhile, the use of a heterologous (or live virus) jab for the additional dose may also be considered based on vaccine supply and access considerations.

"When implementing this recommendation, countries should initially aim at maximising two-dose coverage in that population, and thereafter administer the third dose, starting in the oldest age groups," SAGE said.

The WHO had earlier called for a global moratorium on Covid-19 booster doses, aiming for a more equitable distribution of vaccines globally to enable every country to vaccinate at least 40 percent of its population.

Last week, the Organization announced an initiative to vaccinate 40 per cent of the population of every country against Covid-19 by the end of 2021, and 70 per cent by mid-2022.

This drive would prioritise vaccine delivery to low-income countries, particularly those in Africa.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Who's strategic advisory groupindiaGenevaWorld Health OrganizationWhoWorld healthU of u healthFinance and healthIndiUk-indiaNational public health organization
Open in App

Related Stories

NationalJ&K: Water Level Of Chenab River In Akhnoor Rises After Significant Dip (Watch Video)

MumbaiMumbai: Gold Sales Cross ₹12,000 Crores Nationwide on Akshaya Tritiya; Mumbai MMR Sees ₹800 Crores Trade

NationalAkshaya Tritiya 2025: Gold Market Sees Huge Footfall Despite Price Hike (Watch Video)

HealthWho’s Steering Indian Health Policy? COP11 Puts Foreign Interference in the Spotlight

MaharashtraOver 10,000 Pakistani Nationals Traced in Maharashtra and Delhi Post-Palgham Terror Attack

Health Realted Stories

HealthShingles vaccine can protect heart health up to 8 years: Study

HealthStudy shows HIV prevalence rising in older adults, but prevention focusses youth

HealthJharkhand govt to withdraw order removing RIMS Director, HC disposes of petition

HealthElderly dementia patients in S. Korea hold assets worth 6.4 pc of GDP: Report

HealthHere’s how Ayurveda tourism is redefining wellness travel